Form 4: MACOM Director Sells $29M in Shares via Trusts

MACOM Technology Solutions Holdings Director Susan Ocampo reported the sale of 119,877 shares of common stock through family trusts over two days in February 2026.

Summary

• Director Susan Ocampo reported the sale of 119,877 shares of MACOM Technology Solutions Holdings, Inc. common stock.
• The sales occurred on February 12 and February 13, 2026, through Ocampo Family Trusts.
• Transaction prices ranged from approximately $240.00 to $245.205 per share, with a total value of approximately $29.0 million.
• These transactions were conducted under a Rule 10b5-1 trading plan, indicating they were pre-scheduled.
• Following these transactions, Ocampo's indirect beneficial ownership through various trusts stands at 4,158,446 shares via Ocampo Family Trusts, 2,577,334 shares via trusts for children, and 938,631 shares via a GRAT.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a moderately negative signal due to the significant volume of shares sold by a director, although the impact is tempered by the disclosure that the transactions were pre-planned under Rule 10b5-1.

Negatives

• Director Susan Ocampo sold a significant number of shares (119,877 shares) through family trusts.
• The total value of the shares sold is approximately $29.0 million, which represents a substantial insider divestment.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider selling, even under a Rule 10b5-1 plan, is a routine event for executives managing personal portfolios and does not necessarily reflect a change in the company's fundamental outlook or broader industry trends. It's a common practice for diversification or liquidity.

Comparison to Industry Standards

• StockSavvy.ai observes that insider transactions of this magnitude are not uncommon for long-serving directors or founders of established technology companies like MACOM, which operates in the semiconductor industry.
• Similar planned sales are seen at companies such as Broadcom (AVGO) or Analog Devices (ADI) where executives periodically liquidate portions of their holdings for personal financial planning.

Related Party Transactions

• Director Susan Ocampo's sales were conducted through Ocampo Family Trusts, trusts for her children, and a GRAT, all of which are considered related parties.

Stakeholder Impact

• Shareholders: May perceive the insider selling as a negative signal, potentially leading to short-term price pressure.

Key Dates

Recommendation

The significant insider selling by a director, even under a pre-arranged 10b5-1 plan, typically warrants a cautious stance. While not a direct indictment of the company's future prospects, it suggests that the insider is taking profits or diversifying, which can be interpreted as the stock being fully valued. Therefore, a 'hold' recommendation is appropriate to observe further developments rather than an immediate 'sell' given the planned nature of the transactions.

Keywords

MACOM Technology Solutions Holdings, MTSI, Susan Ocampo, Insider Sale, Form 4, Stock Transaction, Director Sale, Equity Disposal, Rule 10b5-1